Sandra Calvin

SVP, Chief Accounting Officer, Travere Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$4.2M

Companies

Latest trade

Sep 15, 2026

Companies

Travere Therapeutics, Inc.SVP, Chief Accounting Officer −$4.2M

Trades

TVTX Sold 5,375 shares at $62.33 · planned $0.3M Sep 15

TVTX Sold 21,977 shares at $41.07 · planned $0.9M Apr 14

TVTX Sold 4,333 shares at $32.12 $0.1M Feb 3

TVTX Sold 7,402 shares at $40.00 · planned $0.3M Dec 24

TVTX Sold 2,910 shares at $36.00 · planned $0.1M Dec 15

TVTX Sold 67,115 shares at $36.00 · planned $2.4M Nov 4

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.